Last updated on June 2018

Phase III Study of Idasanutlin


Brief description of study

People with Relapsed/Refractory Acute Myeloid Leukemia are asked to participate in a research study being conducted by Northwell Health.

Clinical Study Identifier: TX200742

Contact Investigators or Research Sites near you

Start Over

Carolyn Pellizzari, Study Coordinator

Biomedical Research Alliance of New York
Lake Success, NY USA
  Connect »